Thyroidectomy in children and adolescents: a systematic review
Review Article

Thyroidectomy in children and adolescents: a systematic review

Angeliki Vouchara1, Angeliki Chorti1, Georgios Tzikos1 ORCID logo, Alexandra Menni1 ORCID logo, Stergianna Ntouma2, Styliani Giza2, Maria Tzitiridou-Chatzopoulou3, Sohail Bakkar4 ORCID logo, Assimina Galli-Tsinopoulou2 ORCID logo, Antonios Michalopoulos1, Theodosios S. Papavramidis1 ORCID logo

11st Propaedeutic Department of Surgery, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, Greece; 22nd Department of Paediatrics, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, Greece; 3Department of Midwifery, University of Western Macedonia, Ptolemaida, Greece; 4Department of General and Specialized Surgery, Faculty of Medicine, the Hashemite University, Zarqa, Jordan

Contributions: (I) Conception and design: A Vouchara, TS Papavramidis, A Galli-Tsinopoulou; (II) Administrative support: S Bakkar, G Tzikos, A Menni, A Chorti; (III) Provision of study materials or patients: A Menni, A Vouchara; (IV) Collection and assembly of data: S Ntouma, S Giza, M Tzitiridou-Chatzopoulou; (V) Data analysis and interpretation: A Vouchara, G Tzikos, A Chorti; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

Correspondence to: Prof. Theodosios S. Papavramidis, MD, PhD. 1st Propaedeutic Department of Surgery, Aristotle University of Thessaloniki, AHEPA University General Hospital, Stilponos Kiriakidi 1, 54621 Thessaloniki, Greece. Email: papavramidis@hotmail.com.

Background: Thyroid surgery in pediatric population is not as common as that in adults, although they share the same indications, techniques and complications. This review aims to evaluate the surgical management of thyroid disease in patients under 18 years old.

Methods: We conducted a bibliographic search in the international literature. Data from the identified studies such as demographics, indication for surgery, type of procedure, complications and length of hospital stay were recorded. A retrospective review study of all patients under 18 years old who underwent thyroidectomy was performed.

Results: We included 37 retrospective studies and a total of 12,728 patients. Thyroidectomy was more common in female patients and the mean age was approximately 14 years old. The leading indication for surgery was benign thyroid pathology. Due to the surgical treatments’ safety and effectiveness in young patients, total and subtotal thyroidectomy, whether for malignancies or benign diseases, is becoming more popular today. The most often occurring complication of pediatric thyroid surgery is hypoparathyroidism. Despite the high likelihood of recurrence of pediatric malignancies, overall survival rates of pediatric thyroid cancer are excellent.

Conclusions: Thyroidectomy performed by high-volume thyroid surgeons in children and adolescents is considered an efficient and safe method of treatment of thyroid disease.

Keywords: Pediatric thyroidectomy; thyroid surgery; thyroid disease; thyroid cancer (TC)


Submitted Jan 26, 2024. Accepted for publication Mar 28, 2024. Published online May 27, 2024.

doi: 10.21037/gs-24-16


Highlight box

Key findings

• This study underscores the efficacy and safety of thyroidectomy as a primary intervention for pediatric thyroid pathology. Female predominance was observed among patients. Hypoparathyroidism, whether transient or permanent, emerged as the principal complication. Despite potential recurrence in pediatric thyroid cancer, overall survival rates were consistently excellent. Surgical approaches are witnessing increased favor due to their demonstrated safety and efficacy in managing pediatric thyroid diseases.

What is known and what is new?

• In previous years, due to limited pediatric expertise, a relatively conservative approach was favored for managing thyroid disease in children and adolescents. This approach included antithyroid medication, radioiodine treatment, and restricted resections.

• Pediatric thyroid surgery, whether for malignancies or benign conditions, has been established as a safe procedure. Complications are notably rare, hospitalization periods are short, and the impact on healthcare resources remains minimal.

What is the implication, and what should change now?

• The results emphasize the effectiveness of thyroidectomy in children and adolescents, signaling a need for updated clinical guidelines, enhanced surgeon training, and specific patient education. Furthermore, essential research is required to identify factors contributing to favorable outcomes in pediatric thyroid surgery.


Introduction

Pediatric thyroid disease includes either benign or malignant situations. The most frequent benign pathologies involve Graves’ disease, toxic adenoma, congenital hyperthyroidism, thyroid nodules and goiter. Additionally, differentiated thyroid cancers (TCs) such as papillary, follicular and myeloid cancer are the most commonly malignancies in children. In case of medullary cancer, familial syndromes should be investigated (1,2).

For TC as well as for some benign thyroid disorders, total and subtotal thyroidectomy is the treatment option in pediatric patients, while prophylactic procedure is left for high-risk cancer development in the future. Since thyroid pathology favors malignancy in younger ages, lymph node dissection is common (3).

Endocrine surgery in patients under 18 years of age has similar philosophy as adult surgery concerning the surgical techniques. Major complications from thyroidectomy include recurrent laryngeal nerve (RLN) or superior laryngeal nerve palsy, respiratory complications, trauma infection, bleeding and hematoma, permanent and temporary hypoparathyroidism. The procedure type, referring to lobectomy, total thyroidectomy with or without node dissection, affects complication rates and hospital length of stay. Hospitalization of underage patients usually requires accompany of a family member during hospitalization due to the emotional charge of the patient. One day hospitalization after pediatric thyroidectomy is the common practice (4,5).

In this review we aimed to evaluate the field of thyroid surgical practice in patients less than 18 years old. Our objective was to emphasize the value of preoperative examinations, the type of the procedure, the increasing preference of surgery instead of more conservative treatment, the recurrence rate and follow-up needed. We present this article in accordance with the PRISMA reporting checklist (available at https://gs.amegroups.com/article/view/10.21037/gs-24-16/rc).


Methods

The literature search was conducted in the PubMed, Scopus and Embase databases until March 2023 using the following Mesh terms: (thyroidectomy) AND (pediatric), (thyroidectomy) AND (children), (thyroidectomy) AND (adolescence), (thyroidectomy) using the age frame child (from birth to 18 years old age). The search was limited to articles written in English without any restriction on period. Studies included patients older than 18 years old were excluded.

Data including time period, study design, patients’ demographics, indication for thyroid surgery, surgical procedures, postoperative complications, and outcomes were collected.


Results

The literature search identified 11,225 articles, 11,108 of which were excluded from title and abstract screening and an additional 81 articles were excluded by the full text. Thirty-seven retrospective studies were included in our systematic review (Figure 1).

Figure 1 The PRISMA flowchart.

A literature review was performed and 37 articles of thyroid surgery in pediatric population were selected and summarized in (Table 1).

Table 1

Characteristics of included studies on pediatric thyroid surgery

Source Time period Study design Patients (n) Mean age, years Sex Pathology Type of surgery Complications Mean postoperative hospital stay (days) Follow-up, mean (range)
Sosnowska-Sienkiewicz et al., 2024 (6) 2013–2022 Retrospective study 148 15 Female 113 (76%), male 35 (24%) Goiter 56; Graves’ disease 3; Hashimoto’s disease 13; PTC 48; follicular thyroid carcinoma 6; medullary thyroid carcinoma 2; lymphoepithelial cyst 1; sinus histiocytosis 2; hyalinizing trabecular adenoma 1; Burkitt’s lymphoma 1; mature teratoma 1; thyroid tissue 5; thyroid adenoma 20 TT 64, HT 95, + LN dissection 45, reoperation 11 Early complications 43 (39.05%) 6 Until they were 18 years old
   -Transient retrograde laryngeal nerve palsy 6
   -Transient hypoparathyroidism 37
Late complications 3 (2.03%)
   -Vocal cord paralysis (required a tracheostomy) 1
   -Hypoparathyroidism 2
Quaglino et al., 2023 (7) 2019–2022 Retrospective review study 25 12.64±3.86 Female 15 (60%), male 10 (40%) Graves’ disease 6 TT 20 (80%) Transient hypoparathyroidism 5 3.4 (range, 2.6–4.5) 3 months
Uninodular thyroid goiter 3 TT + unilateral LN dissection of the central cervical compartment 3, HT 5 (20%) Persistent hypoparathyroidism 1
Multinodular thyroid goiter 4
Papillary thyroid cancer 8
Medullary thyroid cancer 3
Completion thyroidectomy (in previous papillary thyroid cancer) 1
Weber et al., 2023 (8) 2017–2022 Prospective study 604 15.4 Female 453 (75%), male 151 (25%) Nodular goitre (35.6%) Not reported Early RLN injury 27 (4.9%) Not reported Not reported
Follicular adenoma (30.1%) Persistent RLN injury 4 (0.7%)
Graves' disease (28.5%)
Malignancy 126
PTC 77.8%
Follicular thyroid carcinoma 10.3%
Medullary thyroid carcinoma 8.7%
Vieira et al., 2023 (9) 2010–2021 Retrospective study 14 15.9 Female 12, male 2 Follicular adenoma 6 TT 6 (including 1 completion thyroidectomy), HT 9 Persistent bilateral lesion of the RLN 1 Not reported Not reported
Colloid nodular goiter 6 Cervical hematoma 1
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features 1 Transient hypoparathyroidism 1
Papillary carcinoma 1
MEN2A 1
Scholfield et al., 2023 (10) 1986–2021 Retrospective review study 307 Not reported Not reported Well-differentiated thyroid carcinoma 307 TT 212 (69%), HT 95 (31%) Temporary unilateral vocal cord palsy 1.06% 61 months
Permanent vocal cord palsy 0.7%
Transient hypocalcemia 32.6%
Permanent hypocalcemia 5.2%
Reiter et al., 2023 (11) 2015–2019 Retrospective cohort study 1,595 14.9 Female 1,234 (77.4%), male 361 (22.4%) Benign 1,091 (68.4%) TT 1,595 Minor 8 Benign 1.7 30 days
     -Thyrotoxicosis 637 (58.4%) Major 49 Malignant 1.9
     -Nontoxic goiter 153 (14.0%) Readmissions 38
     -MEN 110 (10.1%) Reoperations 12
Malignant 504 (31.6%)
Willobee et al., 2023 (12) 1997–2012 Retrospective study 5,633 16 Female (79%), male (21%) Malignancy (46%) TT 3,253 Hypocalcemia 174 (9%)
Goiter (42%) HT 2,380 Nerve injury 57 (3%)
Elgendy et al., 2022 (13) 2011–2021 Retrospective study 32 14 (range, 5–18) Female 26 (81.25%), male 6 (18.75%) Papillary carcinoma 24 (75%) TT 25 (78%) Chylous leak 1 Not reported 54 (range, 9–117) months
Follicular carcinoma 6 (18.75%) TT only 9 Transient hypoparathyroidism 3
Medullary carcinoma 2 (6.25%) TT and node dissection 16 Transient unilateral RLN palsy 3
TT and central node dissection 16 Bilateral RLN injury 1 (required an urgent tracheostomy procedure)
TT and central and lateral node dissection 7
HT 7 (22%)
Bukarica et al., 2022 (14) 2017–2022 Retrospective observational study and systematic literature review 17 14.8 (range, 5–17) Female 14 (82.4%), male 3 (17.6%) Malignant (n=3) Total surgeries 19 Wound infection 1 4 Not reported
     -Papillary carcinoma      -Total thyroidectomies 8 Transient hypocalcemia 1
Benign (n=14)      -Lobectomy 10 Transient RLN injury 2
     -Hyperplastic diffuse colloid goiter      -Central neck dissections 3
     -Cystic nodule
     -Follicular adenoma
     -Hashimoto thyroiditis
     -Toxic adenoma
Alfonso et al., 2022 (15) 2010–2020 Retrospective study 11 9.8±3.9 Female 7 (63%), male 4 (37%) Thyroid nodule 1 TT 7 Transient hypocalcemia 1 (8.6%) 2.35 (range, 1.25–5) 4 years
Graves-Basedow disease 1 HT 4 Transient RLN neuropraxia 2 (16.6%)
Follicular adenoma 1 Completion thyroidectomy 1
Papillary thyroid cancer 5
Medullary thyroid cancer 3
García-García et al., 2022 (16) 2000–2020 Retrospective study 39 (range, 3.67–14) Female 26 (66.7%), male 13 (33.3%) MEN2A 25 (64.1%) Total surgeries 42 Temporary hypoparathyroidism 9/39 (23.1%) Not reported Not reported
Differentiated carcinoma 8 (20.5%)      -TT 29 Permanent hypoparathyroidism 3/39 (7.7%)
Medullary carcinoma 2 (5.1%)      -HT 3
Simple MNG 4 (10.3%)      -Completion HT with central neck dissection 3
     -TT with central neck dissection 7
Al-Qurayshi et al., 2022 (17) 2010–2014 Retrospective cross-sectional analysis 361 13.5±0.2 Female 288 (79.8%), male 73 (20.2%) Thyroid cancer (19.0%) Lobectomy 29.11% Postoperative complications were reported in 14.2% of the sample and hypocalcemia was the most common complication (98.2%) Pediatrics-only hospital 2.44, general hospital 2.11 Not reported
MEN2 (5.4%) Lobectomy followed by completion thyroidectomy 3.22%
Toxic nodular disease (33.6%) TT 67.66%
Non-toxic benign disease (42.0%)
Pereira et al., 2021 (18) 2000–2019 Retrospective study 47 8.9±3.9 Female 29 (61.7%), male 18 (38.3%) MEN2A 29 TT 38 (73.7% of which were prophylactic) Hematoma 0 1.3±0.6 29 (range, 6–171) months
MEN2B 1 Double HT 3 Wound infection 0
Papillary carcinoma 5 HT 5 RLN injury 0
Follicular adenoma 5 + Lymphadenectomy 5 Transient asymptomatic hypoparathyroidism 7
Multinodular goiter 4 Persistent symptomatic hypoparathyroidism 1
Follicular carcinoma 1
Thyroglossal duct papillary carcinoma 1
Graves’ disease 1
van Rooijen et al., 2021 (19) 2013–2020 Retrospective study 48 14.6 (range, 3.9 –17.9) Female 37 (77.1%), male 11 (22.9%) Graves’ disease 12 (25%) Total surgeries 52 Rapid resolved hypocalcemia 3 Not reported 1.6 (range, 0.1–6.0) years
Benign thyroid nodule(s) 16 (33.3%)      -HT 19 (39.6%) Transient hypocalcemia 10
Hashimoto’s disease 1 (2.1%)      -TT only 18 (37.5%) Permanent hypocalcemia 6
Piriform sinus fistula 2 (4.2%)      -TT in two tempi only 2 (4.2%) Transient RLN injury 4
Goiter due to Pendred syndrome 1 (2.1%)      -TT in two tempi with central neck dissection 1 (2.1%) Permanent RLN injury 1
Goiter due to a congenital activating TSH receptor mutation 1 (2.1%)      -TT plus central neck dissection 3 (6.3%) Keloid 8
MEN2A 3 (6.3%)      -TT plus central and lateral neck dissection 5 (10.4%)
Papillary carcinoma 12 (25%)
de Jong et al., 2021 (20) 2003–2018 Retrospective review study 72 12.7 (range, 1–18) Female 52 (72%), male 20 (28%) Papillary cancer 57 (79.2%) HT 24 Bleeding 0 Not reported 39.7 months
Follicular cancer 15 (20.8%) TT alone 10 Wound infections
LN metastases 41 (56.9%) TT + central neck dissection 4 Transient hypoparathyroidism 27
TT + central & lateral neck dissection 33 Permanent hypoparathyroidism 18
Debulking 1 Unilateral RLN injury
Completion thyroidectomy only 18 Excision of RLN owing to tumor infiltration
Completion thyroidectomy + central neck dissection 2
Additional central & lateral neck dissection 2
Almosallam et al., 2020 (21) 2000–2014 Retrospective study 103 13.2 (range, 2–18) Female 80 (78%), male 23 (22%) Benign 37 (36%) Total surgeries 112 Operative complications were observed in 22 patients (19.6%) Mean length of stay: benign 5.2; malignant 4 71.7 (median 60.0, range 9–148) months
     -Normal thyroid tissue 14 (13.5%)      -TT (50%) Transient hypocalcemia 20
     -Colloid nodule 14 (13.5%)      -HT (17%) Permanent hypocalcemia 3
     -Cyst 2 (1.9%)      -Completion thyroidectomy (31%) Transient unilateral RLN palsy 3
     -Adenoma 3 (2.9%)      -Subtotal thyroidectomy (1.7%) Permanent unilateral RLN palsy 3
     -Thyroiditis 3 (2.9%)      -Neck dissection was performed in 59 patients Bleeding/hematoma 0
     -Graves’ disease 1 (1.0%) Wound infection 0
Thyroid cancer 66 (64%) Tracheal injury 0
     -Papillary 61 (59%)
     -Follicular 3 (2.9%)
     -Medullary 2 (1.9%)
Bilić et al., 2020 (22) 2011–2020 Retrospective study 58 14.4 (range, 6–18) Female 54 (93.1%), male 4 (6.9%) Multinodular goiters 23 Total surgeries 58 Transient hypoparathyroidism 11 (19%) Not reported Not reported
Follicular adenoma 9      -Lobectomies 21 Permanent hypoparathyroidism 2 (3.4%)
Papillary cancer 25      -Total thyroidectomies 37 Permanent unilateral recurrent nerve palsy 1
+ level VI cervical LN metastasis 4      -Paratracheal neck dissections 12 Unilateral resection of spinal accessory nerve (nXI) 1
+ level II–IV cervical LN metastasis 10      -Selective neck dissections 10 A few local wound infections
Medullary cancer with unilateral RLN invasion 1      -Sternotomy with partial pleurectomy 1
Dream et al., 2020 (23) 2015–2019 Retrospective review study 51 15±0.3 (range, 9–18) Female 40 (79%), male 11 (21%) Graves’ disease (55%) TT 36 Wound complication 3 6 h 13±7 days
Thyroid cancer (17%) HT 13 Hematoma 1
Thyroid nodule (11%) TT with neck dissection 2 Transient hypoparathyroidism 5
Multinodular goiter (7%) Modified lateral neck dissection 2 Transient hoarseness 1
Hashimoto’s disease (6%) Permanent hypoparathyroidism 2
Toxic adenoma (4%) Permanent RLN injury 0
Utria et al., 2020 (24) 2015–2017 Retrospective study 1,300 14±3.5 Female 1,014 (78%), male 286 (22%) Benign 834 (64%) Total thyroidectomies 805 Total 39 1.7 30 days
Malignant 380 (29%) Unilateral thyroidectomies 412 • Readmissions (n=20)
Modified radical neck dissection 83    -Hypocalcemia/hypoparathyroidism 12
   -Remainder included thyroid malignancy 4
   -Nausea and vomiting 1
   -Postprocedural endocrine disorder 1
   -Localized swelling 1
   -Unknown 1
• Infection 6, prolonged intubation 5, reoperation 5, DVT 2, transfusion 1, peripheral nerve injury 1, urinary tract infection 1, reintubation 1
Babala et al., 2019 (5) 2006–2018 Retrospective study 22 12.6±4.0 Female 15 (68%), male 7 (32%) Papillary carcinoma 12 (55%) TT 18 (82%) Transient hypoparathyroidism 6 (27.3%) Not reported 6 years
MEN2 6 (27.3%) Lobectomy 1 (4.5%) -Symptomatic 1 (4.5%)
Medullary carcinoma 3 (13.7%) Primary surgery on the LNs 1 (13.6%) -Asymptomatic 5 (22.7%)
Follicular cancer 1 Permanent unilateral vocal cord paralysis 1
Neck LN metastases 8 (36.4%)
Distant metastases 6 (27.3%)
Both locations 4 (18.2%)
Patel et al., 2020 (25) 2015–2016 Retrospective study 720 14.1 Female 555 (77%), male 165 (23%) Not reported HT 245 Nerve injury 1, occurrences bleeding/transfusion 1, organ/space surgical site infection 1, related readmission 18, related reoperation 1, seizure 1, superficial incisional surgical site infection 3, superficial wound disruption/dehiscence 2, urinary tract infection 1 1 to 5 years of age: 7.8 30 days
TT 376 Older: 2.1
TT with central neck dissection 99
de Jong et al., 2020 (4) 1998–2018 Retrospective study 106 12 [range 0–18] Female 68 (64.2%), male 38 (35.8) Graves’ disease 52 (49.1%) TT only 83 (78.3) Post-operative transient hypocalcaemia 63 (59.4%) (within 24 h after surgery) 4 (range, 1–15) 6 months
Hereditary medullary thyroid carcinoma 36 (33.9%) TT plus central neck dissection 9 (5.7)
Multinodular goiter 3 (2.8%) TT plus central and lateral neck dissection 14 (13.2) Long-term hypoparathyroidism 23 (21.7%)
Thyroid carcinoma (follicular or papillary) 15 (14.2%)
Jiang et al., 2019 (26) 2010–2016 Retrospective review study 38 14.3 (range, 4.3–18.4) Female 32 (84.2%), male 6 (15.8%) Medullary thyroid carcinoma (associated with MEN2) 4 (10.5%) TT 32 24 (63.2%) hypocalcemia 2.5±1.3 7 years
Classic PTC 14 Completion thyroidectomy with prior lobectomy surgery 6 + neck dissection 14 Permanent hypoparathyroidism 5.3%
Follicular Variant of PTC 3 Transient or permanent RLN paralysis 0
Diffuse Sclerosing Variant of PTC 1
Follicular carcinoma 3
Multinodular goiter 8
Graves’ disease 5
Nordenström et al., 2018 (27) 2004–2014 Retrospective study 274 14 (range, 0–17) Female 215 (78.5%), male 59 (21.5%) Graves’ disease 214 (78.1%) TT 174 Permanent hypoparathyroidism 20 (7.3%) No permanent 1 day 4.8 years
Other benign disease 27 (9.9%) + LN surgery 38 Permanent hypoparathyroidism 2
Thyroid cancer 33 (12%)
Alkhars et al., 2019 (28) 1997–2017 Retrospective review study 75 13.3±3.76 (range, 3–18) Female 60 (80%), male 15 (20%) Follicular adenoma, 54.7% (n=42) TT 54.7% (n=41/75) whereas 13.3% (n=10/75) had associated neck dissection Wound infection 1 Not reported Not reported
Graves’ disease, 13.3% (n=10) Transient XII paralysis which had rapidly recovered 1
Teratoma, 1.3% (n=1) Partial thyroidectomy 45.3% (n=34/75) Bilateral RLN paralysis 1
Ectopic thymic nodule, 1.3% (n=1) Dysphonia with paralysis of the right vocal cord 1
Papillary carcinoma, 14.7% (n=11) Transient hypoparathyroidism 4
Follicular carcinoma 8% (n=6) Permanent hypoparathyroidism 1
Medullary carcinoma 6.7% (n=5)
Bussières et al., 2019 (29) 2006–2015 Retrospective study 98 11.8±4.75 Female 73 (74.5%), male 25 (25.5%) Thyroid nodule 63 (64%) [malignant 23, papillary carcinoma (22/23), follicular carcinoma (1/23)] Total 118 surgeries Wound infection 2 First surgery: 1.42±1.05; second surgery: 1.95±3.33 2.7±2.65 years
     -Prophylactic TT 21 (18%) Postoperative hematoma 1
MEN mutation carrier 21 (22%) [malignant 9, medullary carcinoma (9/21)]      -TT 24 (20%) Parathyroid injury
     -HT 58 (49%) Transient hypocalcemia 16 (13.6%)
Hyperthyroidism 7 (7%)      -HT with branchial remnant excision 7 (6%) Permanent hypocalcemia 2 (1.7%)
Goiter 7 (7%) (malignant 4, papillary carcinoma 4/7)      -LN dissection 3 (3%) RLN injury
     -Other 5 (4%) Transient VC paralysis 2 (1.7%)
Permanent VC paralysis 3 (2.5%)
Zong et al., 2018 (30) 2005–2016 Retrospective study 35 9.5 (range, 4–14) Female 25 (71%), male 10 ( 29%) Follicular adenocarcinoma 1, papillary carcinoma 34 TT 7, HT 6 Hypocalcemia without hypoparathyroidism 3 (lobectomies), hypoparathyroidism 6 (TT) HT 4.1±1.8 HT 3.75 (1.2–4.3) years
TT 9.7±3.4 TT 3.8 (1.3–7) years
Spinelli et al., 2019 (31) 2000–2017 Retrospective study 30 13.73±3.83 (range, 5–18) Female 22 (73%), male 8 (27%) Follicular carcinoma 30 HT 21 (70%) [11 (52%) of them were operated a second time with completion of thyroidectomy], TT 9 (30%), + lymphadenectomy of the central and lateral cervical section was performed in 3 patients (10%) Transitory hypoparathyroidism 4 (57%) 72.8±34.62 (range, 6–120) months 6±3.46 (0.5–10) years
Definitive hypoparathyroidism 2 (28%)
Lesion of the RLN 1 (15%)
Spinelli et al., 2016 (32) 2000–2014 Retrospective review study 250 14.2 (range, 4–18) Female 71 (28.4%), male 179 (71.6%) Papillary carcinoma 250 TT 226/250 (90.4%) Transient hypoparathyroidism 13.6% Not reported 5.8 (range, 1–15) years
Thyroid lobectomy 24/250 (9.6%) Permanent hypoparathyroidism 4.4%
Neck dissection followed TT in 109/115 (94.8%) patients. It followed lobectomy in the remaining 6/115 (5.2%) patients Unilateral vocal fold palsy 5 (2%)
Bilateral vocal fold palsy 2 (0.8%) requiring an urgent tracheostomy
Chen et al., 2015 (33) 1992–2013 Retrospective study 171 15.4 (range, 2.5–18.9) Female 141 (82.3%), male 30 (17.7%) Benign 127 (68.3%), most common follicular adenoma (31.4%), Graves’ disease (11.9%), malignant 59 (31.7%), papillary thyroid cancer 51 (27.4%) 186 operations Transient hypocalcemia 24 (12.9%) with 13 (7.0%) requiring intravenous calcium infusion. Permanent hypoparathyroidism 1 (0.9%). Temporary RLN injury 3 (1.6%). Permanent 0 1 (range, 0–8) 3 (range, 0–17) years
TT 85 (45.7%), completion thyroidectomy 15 (8.1%), HT 79 (42.5%)
Medullary thyroid cancer 5 (2.7%) Local excision or nodulectomy 7 (3.8%)
Follicular thyroid cancer 3 (1.6%) + LN dissection 39 (21.0%)
Central neck (level VI) 23 (12.4%)
Central plus unilateral (levels II–IV) 12 (6.5%)
Central plus bilateral 4 (2.2%)
Sinha et al., 2015 (34) 1987–2011 Retrospective study 61 Benign conditions 12 (range, 5–18) Female 43 (70.5%), male 18 (29.5%) Benign: Benign: Transient hypocalcemia 7 Not reported 1.4 (range, 0.3–14.5) years
     -Graves disease 36 (84%)      -Total 18 (42%) Permanent hypocalcemia 4
Malignant conditions 7.5 (range, 2–17)      -Other 7 (16%) (toxic MNG 1, nontoxic MNG 2, and benign thyroid nodule 4)      -Near-total 9 (21%) Transient hoarseness 4
     -Subtotal 12 (27%) Permanent hoarseness 1
Malignant:      -HT 4 (9%) Bilateral RLN injury 1
     -MEN-2 syndrome 9 (50%) Malignant:
     -Papillary 6 (33%)      -Prophylactic TT for MEN-II 9 (50%)
     -Follicular cancer 2 (11%)      -TT 8 (44.5%) (± LNs dissection)
     -B-cell lymphoma 1 (6%)      -HT 1 (5.5%)
Akkari et al., 2014 (35) 2004–2012 Retrospective study 64 12.5±0.7 Female 48 (75%), male 16 (25%) Thyroid nodule 32 (49.2%) [2 of them had papillary adenocarcinoma (6.3%)] Total surgeries 65 Permanent RLN paralysis 1 (1.1%) Not reported Range, 6–103 months
Toxic MNG 8 (12.3%)      -Enucleation (9.2%) Transient hypoparathyroidism 3 (23.5% of the 34 total thyroidectomies)
Graves’ disease 14 (21.5%)      -Lobectomy with isthmusectomy (38.5%)
Familial MTC 11 (16.9%) [36.3% of them presented one or more sites of C-cell carcinoma]      -TT (44.6%) Permanent hypoparathyroidism 5 (14.7%)
     -TT and LN dissection (7.7%)
Fahrner et al., 2014 (36) 2002–2012 Retrospective study 34 13 (range, 2–17) Female 30 (83%), male 4 (17%) Uni- or multinodular goitre 18 (50%) Total surgeries 36 Persistent hypoparathyroidism 1 (3%) 5 (range, 3–11) 57 (range, 14–130) months
Graves’ disease 9 (25%)      -TT 24 (67%) Persistent recurrent nerve palsy 1 (3%)
Malignancy 6 (17%)      -HT 12 (33%) (2 had a second operation on the contralateral side after initial HT) Transient recurrent nerve palsy 2 (6%)
Genetic tumour predisposition (MEN) 3 (8%)      -+ LN dissection 5 (14%)
Astl et al., 2014 (37) 1991–2006 Retrospective review study 148 13.7 (range, 7–18) Female 121 (81.7%), male 27 (18.3%) Benign 92 (62.2%) Total surgeries 56 Transitory hypocalcaemia 33 (58.9%) Not reported 37–168 (mean 78.4 months)
     -Graves’ disease and toxic goiter 40 TT 52 (prophylactic 4) + neck dissections 19 Permanent hypocalcaemia 4 (7.1%)
     -Toxic adenoma 5 Revision surgeries 4 Lasting hypocalcaemia 1 (1.8%)
     -Nodular goiter 16 Totalization of thyroidectomy 1 Scare hypertrophy 9 (16.1%)
     -Solitary thyroid node 27 Totalization of thyroidectomy with neck dissection 2 Unilateral permanent vocal fold paresis 1 (1.8%) (RLN encased by the tumor)
     -Hashimoto’s thyroiditis 3 Neck dissections 2 Bilateral RLN palsy 0
     -Mechanic syndrome with diffuse goiter 1
Malignant 56 (37.8%)
Papillary cancer 42 (75%)
Follicular cancer 5 (8.9%)
Medullar cancer 9 (16.1%)
MEN2 3 (5.4%)
Scholz et al., 2011 (38) 1970–2004 Retrospective review study 175 12 Female 139 (79.4%), male 36 (20.6%) Nodules 146 (83%) Initial thyroid surgery in 146 patients referred for thyroid nodules Hypocalcemia 12 (6.9%) Not reported Not reported
     -Papillary thyroid cancer 44 nTT 33 Transient hypocalcemia 10 (5.7%)
     -Follicular thyroid cancer 5 Subtotal thyroidectomy 10 Permanent hypocalcemia 2 (1.1%)
     -Clear cell cancer 1 Lobectomy 90 Vocal cord paralysis 3 (1.7%)
     -Medullary thyroid cancer 2 Local excision 13 Transient 1 (0.6%)
     -Benign nodule(s) 88 (cyst 14, adenoma 66, colloid 8) Permanent 2 (1.1%)
     -Thyroiditis 5
     -Histiocytosis 1
Hyperthyroidism 13 (7%)
Goiter 13 (7%)
MEN II 3 (2%)
Raval et al., 2009 (39) 2000–2007 Retrospective review study 31 Benign 11.6 (range, 5–14) Female 25 (80.6%), male 6 (19.4%) Graves’ disease 12 TT 31 Hematoma 0 Benign 2.2 (range, 1–6) Benign 12.9 (range, 6–34) months
Hyperthyroidism not classified as Graves’ disease 2 Wound infection 0
Malignant 13 (range, 8–17) Multinodular goiter 1 RLN palsy or paralysis 0 Malignant 2.1 (range, 1–6) Malignant 17.7 (range, 6–52) months
Papillary thyroid cancer 11 Keloid scar 1
Medullary thyroid cancer 3 Transient hypocalcemia 16
Follicular thyroid cancer 2 Permanent hypocalcemia 2
Astl et al., 2004 (40) 1991–2000 Retrospective study 114 Benign 15.5 Female 99 (86.1%), male 16 (13.9%) Benign 82 (71.9%) TT 49 (43%) Transitory hypocalcaemia 27 (23.7%) Not reported 0–12 months
Malignant 14.7 Graves’ disease 39 (34.2%) nTT 6 (5.3%) Lasting hypocalcaemia 1 (0.86%)
Toxic adenoma 5 (4.4%) HT 36 (31.6%) Keloid scar 12.3%
Polynodular goiter 13 (11.4%) TT 18 (in 4 cases as a two-step procedure) Unilateral RLN paresis 1
Hashimoto thyroiditis 3 (2.6%) TT and selective modified neck dissection 11 (9.6%) (area II–V), nTT 2
Diffuse goiter 1 (0.9%) Revision surgery 6 ( 2 completion of TT with selective neck dissection and 3 selective neck dissection, 1 simple completion of thyroidectomy)
Malign tumor 32 (28.1%)
Papillary cancer 25 (21.9%)
Follicular cancer 4 (3.5%)
Mononodular goiter 22 (19.3%)
Medullar cancer 3 (2.6%)

PTC, papillary carcinoma; TT, total thyroidectomy; HT, hemithyroidectomy; LN, lymph node; RLN, recurrent laryngeal nerve; MNG, multinodular goiter; MEN, multiple endocrine neoplasia; TSH, thyrotropin; DVT, deep vein thrombosis; VC, vocal cord; MTC, medullary thyroid carcinoma; nTT, near TT.

In this systematic review, we added cases from our Department and descriptive statistics was applied. The percentage of criteria fulfillment is shown in Table 2.

Table 2

Descriptive statistics

Criteria Number of cases %
Gender 12,421 97.6
Age 12,421 97.6
Indication for surgery 12,008 94.3
Type of surgery 12,109 95.1
Complications 12,728 100
Length of hospitalization 6,279 49.3

The main results were as follow:

Demographics

In our study, 12,728 patients were enrolled, from whom 9,848 were females (77.4%). The mean age was 13.4±1.93 years old.

Indication for surgery

The indications for thyroid surgery were divided in two main categories; benign disease and malignancy. Benign disease included toxic adenoma, goiter, thyroid nodules, Graves’ disease and congenital hyperthyroidism, which were found in 6,281/12,008 cases (52.3%). Malignant tumors (papillary, follicular and sporadic medullary TC) were found in 4,979/12,008 cases (41.5%), while prophylactic thyroidectomy for multiple endocrine neoplasia type 2 syndrome (MEN-2) was found in 295/12,008 cases (2.5%).

Type of procedures

The most common type of procedure was total thyroidectomy in 7,866/12,109 cases (64.9%), followed by hemithyroidectomy (HT) in 3,214/12,109 cases (26.5%). The percentage of lobectomy was 5.7% (693/12,109 cases), while near-total thyroidectomies were performed in 0.4% (48/12,109 cases). Completion thyroidectomy after HT or lobectomy was performed in 129/12,109 cases (1.1%), due to carcinoma in the final pathology report. The percentage of central and lateral lymph node dissection were 6% (732 cases) and 1.1% (128 cases), respectively.

Complications

The most common complication was hypoparathyroidism (HP) in 1,218/12,728 cases (9.6%), from which 148 cases had permanent HP (12.2%). The second most common complication was RLN palsy in 153/12,728 cases (1.2%), from which 25 cases had permanent nerve injury (16.3%). Other rare complications were wound infection in 18/12,728 (0.14%) cases, keloid formation in 32/12,728 cases (0.25%), hematoma in 8/12,756 cases (0.06%) and chylous leak in 1/12,728 cases (0.008%).

Length of hospitalization

The median length of hospitalization postoperatively was 2,35 days (range, 6 hours to 8.8 days) and the extension was due to postoperative hypocalcemia that emerged intravenous calcium supplementation.


Discussion

Key findings

Thyroidectomy is the treatment option for pediatric TC as well as for some benign thyroid conditions like Graves’ disease and benign thyroid nodules. In cases where there’s an increased risk of future TC, especially within familial syndromes, prophylactic thyroidectomy may be a consideration (19).

Indication for surgery

Bussières et al. in a series of 96 patients found that the most common indication for thyroidectomy in children is thyroid nodules (64%), as well Almosallam et al. and Chen et al. (21,29,33). Dream et al. in a study of 55 patients considered Graves’ disease as the most common indication for operation (55%), followed by TC (17%), thyroid nodule (11%), multinodular goiter (7%), Hashimoto’s disease (6%), and toxic adenoma (4%) (23). According to Fahrner et al., thyroid nodules and Graves’ disease were the leading indication for surgery (75%), while malignancy or familiar MEN-2 were indications in 25%; the incidence of TC was 17% (36). Among 271 patients treated by Nordenström et al., indications for surgery were Graves’ disease in 78.1%, other benign disease 9.9% and TC 12% (27). In a large series of 175 patients, Scholz et al. reported thyroid nodules as the leading indication for thyroidectomy (83%), followed by hyperthyroidism (7%) and goiter (7%); cancer was found in 36%, and thus papillary TC in 85% (38). In Bukarica et al. retrospective observational study, the prevalence of TC increased in adolescence (14). Al-Qurayshi et al. studied 361 patients operated over a period of 5 years in multiple centers; thyroid diseases included 19% TC, 5.4% MEN-2, 33.6% toxic nodular disease, and 42% non-toxic benign disease (17).

Thyroidectomy was conducted preventively in all cases where there was a familial background of medullary thyroid carcinoma by Akkari et al. and in three cases without clinical signs of thyroid tumor with diagnosed RET gene mutation by Astl et al. (35,37). In Raval et al.'s study, the majority of patients who underwent total thyroidectomy for benign conditions either had unsuccessful outcomes with long-term medical treatment (33%) or encountered thyroid storm despite medical management (27%). The efficacy of antithyroid medications like propylthiouracil and methimazole is constrained by issues related to patient compliance, frequent relapses, the onset of hypothyroidism, and the potential for toxicity, including rare instances of fatality. There remains a preference to minimize radioactivity exposure due to theoretical concerns of cancer in radioactive iodine treatment. Besides, total thyroidectomy and near-total thyroidectomy are safe and effective in Graves’ disease in children (39).

Pediatric population with TC often present with advanced disease, namely cervical lymph node involvement (31.5%) and lung metastases (5.7%) (3,29,32,37,40).

Type of surgery

Thyroidectomy is more frequent in female patients (up to 80%) and approximately in individuals aged 14 years old (14,17,19,21,24,25).

Procedures of thyroid gland surgery by Almosallam et al. included total thyroidectomy (50%), HT (17%), completion thyroidectomy (31%), and subtotal thyroidectomy (2%) (21). Patel et al. demographic study of 720 cases stated 245 HT, 376 total thyroidectomies, and 99 total thyroidectomies with central neck dissection (25). Scholz and colleagues reserved near-total thyroidectomy for those patients with confirmed papillary TC. For individuals with unilateral nodules or intermediate cytologic abnormalities (Bethesda III and IV), they recommended lobectomy, followed by completion thyroidectomy if cancer diagnosis is confirmed through operative histology. Preventive total thyroidectomy was performed in 3 patients for MEN-2 syndrome. Another ten patients group underwent completion thyroidectomy for TC after lobectomy (38). According to Spinelli et al., patients with unilateral lesions <2 cm, confined to one lobe, not demonstrating extrathyroidal invasion in neck ultrasound, and with no evidence of distant metastasis were selected for lobectomy. Nodal involvement did not rule out lobectomy (32). Astl et al. accept HT in differentiated TC conforming to T1 N0 M0 classification. Total thyroidectomy is suggested in medullary cancer or advanced papillary cancer. In case of lymph node metastases, therapeutic neck dissection is recommended (40). Bilić et al. advice total thyroidectomy along with occasionalparatracheal neck dissection, while lateral cervical lymph node dissection is only deemed essential when lymph nodes tested positive in fine-needle aspiration (FNA) (22).

Considering that thyroid carcinoma in children often occurs multifocal, and with early lymph node metastasis, Zong et al. found that total thyroidectomy did not have higher complication rate compared to lobectomy, except for the length of hospitalization that was shorter in lobectomy group. Contrariwise, the morbidity increased in staged operation following initial lobectomy because of the risk to identify the parathyroid glands and the RLN during the operation. Therefore, they recommended a primary total thyroidectomy in children with unilateral thyroid carcinoma (30). Multifocality in pediatric TC has been proved not to decrease disease free survival in highly selected cases after total thyroidectomy (41).

Type of TC

Papillary carcinoma (PTC) accounts for the majority of cases of TC (4). De Jong et al. reported 79.2% papillary and 20.8% follicular carcinoma (FTC), similarly Spinelli and Bilić found 90% PTC (4,20,22,31).

Thyroid nodule histology of 146 patients in Scholz et al. study was: TC in 52 cases (Papillary 44, Follicular 5, Clear cell 1, Medullary 2), Benign nodule(s) in 88 cases (Cyst 14, Adenoma 66, Colloid 8, Other 6 (Thyroiditis 5, Histiocytosis 1) (38).

Complications

RLN injury stands out undoubtedly as the most important complication -linked to thyroid surgery (34). Permanent RLN injury is extremely rare in all series reported. De Jong et al. reported a rate of 2.8% of RLN injury (20). Spinelli et al. reported bilateral RLN injury in two of 250 patients (0.8%) operated for papillary TC requiring an urgent tracheostomy (32). Sinha et al. reported two RLNs injury in their series of 61 patients with benign disease. Therefore, they suggested that referring patients for surgery earlier could prevent complications in benign thyroid disease (34). Bukarica et al. reported two transient RLN paralyses in their series of 19 operations, which were successfully treated with neurotropic medicines, glucocorticoids and vasodilators (14). In Scholz et al. series permanent unilateral vocal cord paralysis was documented in 2 children after resection for malignancy (38). Continuous intraoperative laryngeal nerve monitoring (if only it can be detected) has been used by many authors as standard care (22,39). Although intraoperative RLN monitoring may be applied, RLN palsy could still occur (35). According to American Head and Neck Society, intraoperative RLN monitoring should be discussed in every case of thyroid surgery in pediatric population (42).

The most frequent complication observed in pediatric thyroidectomy is either transient or permanent HP (17,20,33,34). HP leads to hypocalcemia of which its expression will be proportional to its severity and speed of onset. Studies reported transient HP after thyroidectomy in individuals under 18 years old from 13.6% to 34.1%, while permanent HP from 1.5% to 23.8% (17).

De Jong et al. claimed that the only factor associated with HP after total thyroidectomy in children was the number of parathyroid glands preserved in situ. HP can occur, and even be permanent, even parathyroid glands remain in situ but not intact (e.g., devascularization) (4,20). The frequency of HP in a 39 patients’ study by García-García et al. was 4 out of 4 when two parathyroids were dissected, 2 out of 10 when only one was dissected, and 6 out of 25 when none were dissected (16). Scholz et al. reported permanent HP up to 4.7%, found only in individuals with bilateral resection; no incidence of permanent HP was found in the remaining operations (38). Nordenström et al. reported an overall incidence of permanent HP after total thyroidectomy in 273 patients up to 7.3% which is higher compared to previous studies (1.5%). This study did not identify any statistically significant risk factors for permanent hypoparathyroidism, and the autotransplantation of parathyroid glands did not prevented it (27). Chen et al. in a cohort of 171 patients reported 12.9% transient HP with 7.0% requiring intravenous calcium correction; only one patient (0.9%) presented with permanent hypoparathyroidism; the risk factors correlated to this included total thyroidectomy, central and bilateral lateral neck dissection, Graves’ disease, and malignancy (33). In Sinha et al. cohort (61 patients), transient hypocalcemia was infrequent following HT. However, its occurrence notably rose with total thyroidectomy, particularly when coupled with lymph node dissection (34). In a series of 29 total thyroidectomies for thyroid malignancy, permanent HP was only seen in patients who underwent lymph node dissection (19).

No correlation between the incidence of HP and indication for surgery was found. Total thyroidectomy and neck dissection carry an increased risk of postoperative hypocalcemia (26).

The increased incidence of postoperative hypocalcemia among patients with Graves’ disease in comparison to the remaining nonmalignant group could be ascribed to the localized thyroiditis-induced inflammation, which leads to greater adherence of the parathyroid glands and renders surgical dissection more challenging (33,35).

Van Rooijen et al. administered active vitamin D (calcitriol) preoperatively to patients undergoing total thyroidectomy in order to mitigate the risk of postoperative hypocalcemia. They also suggested intraoperative localization of the parathyroid glands by fluorescence (19).

Age, cancer type, type of surgery, reoperation, central neck dissection or lateral neck dissection are not significant reasons for these complications. On the contrary, Scholfield et al. showed that N stage and central neck dissection were independent factors for HP and RLN injury (5,10). Aggressive dissection of the central compartment is a risk factor of RLN injury and permanent hypoparathyroidism, or sporadic hemorrhage and readmission to the operation room (23,43).

Explanations of findings

In our study, we found that the most common type of surgery in pediatric population indicated for thyroid surgery was total thyroidectomy, which is in concordance with American and European Thyroid Associations Guidelines (44,45). Papillary thyroid carcinoma seems to be the most common type of TC in pediatric population, which in comparison to adults, pediatric individuals frequently exhibit advanced disease at the time of diagnosis, characterized by increased lymph node involvement, distant metastasis, and multifocal disease (45). There is no consensus about HT and lobectomy oncological outcomes in cases of microcarcinoma and further studies should be applied (45).

In our study, the most common indication for surgery was benign disease, in compliance with most studies in the international literature (17,21,29,38). What should be discussed is that in some studies the main indication for surgery was Graves’ disease, for which medical treatment has been already proposed except for the cases of a thyroid nodule in a background of Graves’ thyroiditis which indicates FNA and surgery (23,27,36,46). Only Raval et al. indicates surgery for Graves’ disease after medical treatment failure (39).

Regarding complications, the most common complication found in our systematic review was transient HP in 9.5% of cases, while in the literature this ranges from 13.6% to 34.1% (17). The percentage of permanent HP in our study was 12.2%, which is claimed as high but in concordance with the literature (1.5% to 23.8%) (17). Nordenström et al. found the rate of permanent HP 7.3% (27). The RLN injury was found in 1.2% of cases, which justifies its rarity. Among these cases, the percentage of permanent nerve palsy was 16.3%, a high one, meaning that in case of nerve injury in children, the palsy is permanent in the majority of cases, may be due to anatomical differences of the young nerve compared to adult cases. Intraoperative neuromonitoring is advised in pediatric thyroid surgery (42).

Pediatric thyroid surgery should be performed by high-volume endocrine surgeons with experience in both pediatric and adult endocrine surgery and of course in endocrine surgical oncology (47). Pediatric thyroid patients have better outcomes when operated on by higher volume surgeons, while Moreno Alfonso et al. suggest that surgeons even if below high-volume threshold but specialized in pediatric surgery can perform thyroidectomies without increase in morbidity and mortality (15,48). Although the UK consensus on pediatric endocrine surgery supports high-volume surgeon to perform thyroidectomies in pediatric population, there is still a debate in the international literature (47,49). In our experience, we suggest pediatric thyroid surgery to be performed by high-volume endocrine surgeons with great experience in both pediatric and adult endocrine surgery.


Conclusions

Thyroidectomy in children and adolescence is a secure and efficient procedure regardless of its being total, HT, or lobectomy. It remains safe even if it is accompanied by central and/or lateral neck dissection. Nowadays, total thyroidectomy has also become the treatment of choice for benign pathology of the thyroid gland. Thyroid gland surgery in patients younger than 18 years is rare, most centers do not have adequate experience, nevertheless surgeons have made the procedure simple, not requiring extra armament, complications are rare or extremely rare, length of stay is short, and the burden on the health system is low. It is of great importance to direct pediatric thyroid surgery in reference with adult centers in order to reduce oncological malpractice, risk of complications and recurrence. The family of these younger patients is emotionally charged but this lasts for only 1 to 2 days.


Acknowledgments

Funding: None.


Footnote

Reporting Checklist: The authors have completed the PRISMA reporting checklist. Available at https://gs.amegroups.com/article/view/10.21037/gs-24-16/rc

Peer Review File: Available at https://gs.amegroups.com/article/view/10.21037/gs-24-16/prf

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-24-16/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Hanba C, Svider PF, Siegel B, et al. Pediatric Thyroidectomy. Otolaryngol Head Neck Surg 2017;156:360-7. [Crossref] [PubMed]
  2. Byeon HK, Kim SB, Oh HS, et al. Clinical Analysis of Pediatric Thyroid Cancer: A Single Medical Institution Experience of 18 Years. Ann Otol Rhinol Laryngol 2019;128:1152-7. [Crossref] [PubMed]
  3. Sosa JA, Tuggle CT, Wang TS, et al. Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocrinol Metab 2008;93:3058-65. [Crossref] [PubMed]
  4. de Jong M, Nounou H, Rozalén García V, et al. Children are at a high risk of hypocalcaemia and hypoparathyroidism after total thyroidectomy. J Pediatr Surg 2020;55:1260-4. [Crossref] [PubMed]
  5. Babala J, Zahradníková P, Béder I, et al. Risk factors of post-surgery complications in children with thyroid cancer. Int J Pediatr Otorhinolaryngol 2019;127:109673. [Crossref] [PubMed]
  6. Sosnowska-Sienkiewicz P, Danielewicz D, Januszkiewicz-Lewandowska D, et al. Thyroid diseases in children and adolescents requiring surgical treatment-indications, techniques, results, and complications based on 10 years of the single center's own experience. Front Endocrinol (Lausanne) 2024;14:1301191. [Crossref] [PubMed]
  7. Quaglino F, Bellocchia AB, Tuli G, et al. Pediatric thyroid surgery: Retrospective analysis on the first 25 pediatric thyroidectomies performed in a reference center for adult thyroid diseases. Front Endocrinol (Lausanne) 2023;14:1126436. [Crossref] [PubMed]
  8. Weber T, Hummel R, Vorländer C, et al. Thyroid surgery in children and adolescents: results from a multi-institutional German and Austrian database. Br J Surg 2023;110:1808-14. [Crossref] [PubMed]
  9. Vieira PM, Barbosa Sequeira J, Santos Monteiro S, et al. Pediatric Thyroidectomy: Experience From a Portuguese Hospital. Cureus 2023;15:e33259. [Crossref] [PubMed]
  10. Scholfield DW, Lopez J, Badillo ND, et al. Complications of Thyroid Cancer Surgery in Pediatric Patients at a Tertiary Cancer Center. Ann Surg Oncol 2023;30:7781-8. [Crossref] [PubMed]
  11. Reiter AJ, Hu A, Sullivan GA, et al. Short-Term Complications After Total Thyroidectomy in Children. J Surg Res 2023;283:758-63. [Crossref] [PubMed]
  12. Willobee BA, Huerta CT, Quiroz HJ, et al. Higher Complication Rates for Total versus Partial Thyroidectomy in the Pediatric Population. J Surg Res 2023;283:449-58. [Crossref] [PubMed]
  13. Elgendy A, Shehata EM, Shehata SM. Outcome and complications after surgery for thyroid carcinoma in pediatric age-an evaluation of practice. World J Surg Oncol 2022;20:293. [Crossref] [PubMed]
  14. Bukarica S, Antić J, Fratrić I, et al. Thyroid Surgery in Children: A 5-Year Retrospective Study at a Single Paediatric Surgical Center and Systematic Review. Children (Basel) 2022;9:1818. [Crossref] [PubMed]
  15. Moreno Alfonso JC, Molina Caballero A, Pérez Martínez A, et al. Pediatric thyroidectomy in a "low volume" institution without protocolization: results and future horizons. Tiroidectomía pediátrica en un centro de “bajo volumen” y sin protocolización: resultados y horizontes. Cir Pediatr 2022;35:125-30. [Crossref] [PubMed]
  16. García-García E, Gómez-Gila AL, Romero-Lluch AR, et al. Hypoparathyroidism after thyroidectomy: A 20-year experience at a children's hospital. Hipoparatiroidismo postiroidectomía: experiencia de 20 años en un hospital infantil. Endocrinol Diabetes Nutr (Engl Ed) 2022;69:92-7. [Crossref] [PubMed]
  17. Al-Qurayshi Z, Peterson JD, Shama MA, et al. Thyroidectomy practice in pediatric population: a national perspective. Am J Otolaryngol 2022;43:103298. [Crossref] [PubMed]
  18. Ordóñez Pereira J, Pérez Egido L, García-Casillas MA, et al. Thyroid surgery in pediatric patients: causes and results. Cir Pediatr 2021;34:9-14.
  19. van Rooijen JJ, van Trotsenburg ASP, van de Berg DJ, et al. Complications After Thyroidectomy in Children: Lymph Node Dissection Is a Risk Factor for Permanent Hypocalcemia. Front Endocrinol (Lausanne) 2021;12:717769. [Crossref] [PubMed]
  20. de Jong MC, Gaze MN, Szychot E, et al. Treating papillary and follicular thyroid cancer in children and young people: Single UK-center experience between 2003 and 2018. J Pediatr Surg 2021;56:534-9. [Crossref] [PubMed]
  21. Almosallam OI, Aseeri A, Alhumaid A, et al. Thyroid surgery in 103 children in a single institution from 2000-2014. Ann Saudi Med 2020;40:316-20. [Crossref] [PubMed]
  22. Bilić M, Dobrić A, Kovač Bilić L, et al. Thyroid Surgery in Children and Adolescents: A 10-year Retrospective Study at a Single Institution. Acta Clin Croat 2020;59:60-5. [Crossref] [PubMed]
  23. Dream S, Wang R, Lovell K, et al. Outpatient thyroidectomy in the pediatric population. Am J Surg 2020;219:890-3. [Crossref] [PubMed]
  24. Utria AF, Goffredo P, Belding-Schmitt M, et al. Practice Patterns and Outcomes of Pediatric Thyroid Surgery: An NSQIP Analysis. J Surg Res 2020;255:181-7. [Crossref] [PubMed]
  25. Patel VA, Khaku A, Carr MM. Pediatric Thyroidectomy: NSQIP-P Analysis of Adverse Perioperative Outcomes. Ann Otol Rhinol Laryngol 2020;129:326-32. [Crossref] [PubMed]
  26. Jiang W, Lee E, Newfield RS. The utility of intact parathyroid hormone level in managing hypocalcemia after thyroidectomy in children. Int J Pediatr Otorhinolaryngol 2019;125:153-8. [Crossref] [PubMed]
  27. Nordenström E, Bergenfelz A, Almquist M. Permanent Hypoparathyroidism After Total Thyroidectomy in Children: Results from a National Registry. World J Surg 2018;42:2858-63. [Crossref] [PubMed]
  28. Alkhars A, Abouzayd M, Rouf CE, et al. Pediatric thyroid surgery: experience in 75 consecutive thyroidectomies. Eur Arch Otorhinolaryngol 2019;276:217-22. [Crossref] [PubMed]
  29. Bussières V, Roy S, Deladoey J, et al. Pediatric thyroidectomy: Favorable outcomes can be achieved by a multidisciplinary team of pediatric providers. J Pediatr Surg 2019;54:527-30. [Crossref] [PubMed]
  30. Zong Y, Li K, Dong K, et al. The surgical choice for unilateral thyroid carcinoma in pediatrics: Lobectomy or total thyroidectomy? J Pediatr Surg 2018;53:2449-53. [Crossref] [PubMed]
  31. Spinelli C, Rallo L, Morganti R, et al. Surgical management of follicular thyroid carcinoma in children and adolescents: A study of 30 cases. J Pediatr Surg 2019;54:521-6. [Crossref] [PubMed]
  32. Spinelli C, Strambi S, Rossi L, et al. Surgical management of papillary thyroid carcinoma in childhood and adolescence: an Italian multicenter study on 250 patients. J Endocrinol Invest 2016;39:1055-9. [Crossref] [PubMed]
  33. Chen Y, Masiakos PT, Gaz RD, et al. Pediatric thyroidectomy in a high volume thyroid surgery center: Risk factors for postoperative hypocalcemia. J Pediatr Surg 2015;50:1316-9. [Crossref] [PubMed]
  34. Sinha CK, Decoppi P, Pierro A, et al. Thyroid Surgery in Children: Clinical Outcomes. Eur J Pediatr Surg 2015;25:425-9. [Crossref] [PubMed]
  35. Akkari M, Makeieff M, Jeandel C, et al. Thyroid surgery in children and adolescents: a series of 65 cases. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:293-7. [Crossref] [PubMed]
  36. Fahrner R, Ubersax L, Mettler A, et al. Paediatric thyroid surgery is safe--experiences at a tertiary surgical centre. Swiss Med Wkly 2014;144:w13939. [Crossref] [PubMed]
  37. Astl J, Chovanec M, Lukeš P, et al. Thyroid carcinoma surgery in children and adolescents - 15 years experience surgery of pediatric thyroid carcinoma. Int J Pediatr Otorhinolaryngol 2014;78:990-4. [Crossref] [PubMed]
  38. Scholz S, Smith JR, Chaignaud B, et al. Thyroid surgery at Children's Hospital Boston: a 35-year single-institution experience. J Pediatr Surg 2011;46:437-42. [Crossref] [PubMed]
  39. Raval MV, Browne M, Chin AC, et al. Total thyroidectomy for benign disease in the pediatric patient--feasible and safe. J Pediatr Surg 2009;44:1529-33. [Crossref] [PubMed]
  40. Astl J, Dvoráková M, Vlcek P, et al. Thyroid surgery in children and adolescents. Int J Pediatr Otorhinolaryngol 2004;68:1273-8. [Crossref] [PubMed]
  41. Xu Y, Shi L, Wu J, et al. Prognostic Value of Tumor Multifocality in Pediatric Papillary Thyroid Carcinoma: A Real-Life Multicentric Study. Otolaryngol Head Neck Surg 2023;169:1606-14. [Crossref] [PubMed]
  42. Diercks GR, Rastatter JC, Kazahaya K, et al. Pediatric intraoperative nerve monitoring during thyroid surgery: A review from the American Head and Neck Society Endocrine Surgery Section and the International Neural Monitoring Study Group. Head Neck 2022;44:1468-80. [Crossref] [PubMed]
  43. Bruss DM, Kovacs AJ, Kashmiri H, et al. Initial outcomes at a nascent tertiary pediatric thyroid surgical center. Int J Pediatr Otorhinolaryngol 2021;143:110639. [Crossref] [PubMed]
  44. Francis GL, Waguespack SG, Bauer AJ, et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015;25:716-59. [Crossref] [PubMed]
  45. Lebbink CA, Links TP, Czarniecka A, et al. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J 2022;11:e220146. [Crossref] [PubMed]
  46. Quintanilla-Dieck L. The management of pediatric Graves' disease. Curr Opin Otolaryngol Head Neck Surg 2023;31:419-23. [Crossref] [PubMed]
  47. Howard SR, Freeston S, Harrison B, et al. Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline. Endocr Relat Cancer 2022;29:G1-G33. [Crossref] [PubMed]
  48. Olson SL, Ingram ME, Graffy PM, et al. Effect of surgeon volume on pediatric thyroid surgery outcomes: A systematic review. J Pediatr Surg 2022;57:208-15. [Crossref] [PubMed]
  49. Olson SL, Ingram ME, Samis J, et al. Surgeon perceptions of volume threshold and essential practices for pediatric thyroidectomy. J Pediatr Surg 2022;57:414-20. [Crossref] [PubMed]
Cite this article as: Vouchara A, Chorti A, Tzikos G, Menni A, Ntouma S, Giza S, Tzitiridou-Chatzopoulou M, Bakkar S, Galli-Tsinopoulou A, Michalopoulos A, Papavramidis TS. Thyroidectomy in children and adolescents: a systematic review. Gland Surg 2024;13(5):697-712. doi: 10.21037/gs-24-16

Download Citation